SARS-CoV

CAS No.	Product Name	Inquiry
	Antiviral agent 15
	Antiviral agent 54
	Antiviral-agent-15 Antiviral agent 15 (Compound 15f) is a Clofazimine derivative with antiviral effects. Antiviral agent 15 inhibits both rabies virus and pseudo-typed SARS-CoV-2 with EC50 values of 1.45 μM and 14.6 μM, respectively.
	Apelin-17(human, bovine) TFA
	Apelin-36(human) TFA
	Azelastine-13C,d3
	Azelastine-13C,d3 hydrochloride
	Azelastine-13C-d3 Azelastine-13C,d3 is deuterium labeled Azelastine. Azelastine, an antihistamine, is a potent and selective histamine 1 (H1) antagonist. Azelastine can be used for the research of allergic rhinitis, asthma, diabetic hyperlipidemic and SARS-CoV-2.
	Azelastine-13C-d3-hydrochloride Azelastine-13C,d3 hydrochloride is the 13C- and deuterium labeled Azelastine hydrochloride. Azelastine-13C,d3 hydrochloride, an antihistamine, is a potent and selective histamine 1 (H1) antagonist. Azelastine-13C,d3 hydrochloride can be used for the research of allergic rhinitis, asthma, diabetic hyperlipidemic and SARS-CoV-2.
	Bromhexine-d3 hydrochloride
	Bromhexine-d3-hydrochloride Bromhexine-d3 (hydrochloride) is deuterium labeled Bromhexine (hydrochloride). Bromhexine hydrochloride is a potent and specific TMPRSS2 protease inhibitor with an IC50 of 0.75 μM. Bromhexine hydrochloride can prevent and manage SARS-CoV-2 infection. Bromhexine hydrochloride is an Autophagy agonist. Bromhexine hydrochloride is a mucolytic cough suppressant and has the potential for a range of respiratory conditions.
	BZG2
	CDK9-IN-25
	CET-1
	Chloroquine-d4 phosphate
	Chloroquine-d4-phosphate Chloroquine-d4 phosphate is the deuterium labeled Chloroquine phosphate. Chloroquine phosphate is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis. Chloroquine phosphate is an Autophagy and toll-like receptors (TLRs) inhibitor. Chloroquine phosphate is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro (EC50=1.13 μM).
	Citrullinated LL-37 1cit
	Coronastat Coronastat is a potent inhibitor of the SARS-CoV-2 3CL protease. The SARS-CoV-2 3CL protease is a critical drug target for small molecule COVID-19, given its likely druggability and essentiality in the viral maturation and replication cycle.
	CTSL/B-IN-1
	D-4-77

※ Please kindly note that our services are for research use only.